Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$8.01 - $8.64 $35,123 - $37,886
-4,385 Reduced 27.51%
11,554 $95,000
Q1 2024

May 03, 2024

SELL
$8.02 - $8.67 $44,470 - $48,075
-5,545 Reduced 25.81%
15,939 $135,000
Q4 2023

Feb 09, 2024

SELL
$7.78 - $8.62 $11,296 - $12,516
-1,452 Reduced 6.33%
21,484 $176,000
Q3 2023

Nov 13, 2023

BUY
$7.85 - $8.94 $48,960 - $55,758
6,237 Added 37.35%
22,936 $191,000
Q2 2023

Aug 08, 2023

SELL
$8.04 - $9.0 $42,145 - $47,178
-5,242 Reduced 23.89%
16,699 $139,000
Q1 2023

May 04, 2023

BUY
$7.57 - $8.37 $35,526 - $39,280
4,693 Added 27.21%
21,941 $178,000
Q4 2022

Feb 10, 2023

SELL
$5.96 - $8.06 $19,006 - $25,703
-3,189 Reduced 15.6%
17,248 $137,000
Q3 2022

Nov 04, 2022

BUY
$5.63 - $7.5 $115,060 - $153,277
20,437 New
20,437 $125,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $43.4B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Commerce Bank Portfolio

Follow Commerce Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commerce Bank, based on Form 13F filings with the SEC.

News

Stay updated on Commerce Bank with notifications on news.